Stock Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

The following table summarizes the activity related to options during 2025:

	Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (In millions)
Outstanding at January 1	3,837,588	$	16.00
Options granted	—	—
Options exercised	(87,500)	10.12			—
Options expired	(312,718)	27.16
Options cancelled	(801,777)	11.98
Outstanding at December 31	2,635,593	15.67		3.3	—
Vested and expected to vest at December 31	2,635,593	15.67		3.3	—
Exercisable at December 31	2,635,593	15.67		3.3	—
Available for grant at December 31	23,537,236

Schedule of Significant Options Groups Outstanding

Significant option groups outstanding at December 31, 2025 and related weighted average exercise price and remaining contractual term information follows:

Grant Date	Options Outstanding	Options Exercisable	Exercise Price		Remaining Contractual Term (Years)
2/25/2020	1,986,167	1,986,167	$	10.12	4.16
2/27/2017	330,668	330,668	35.26		1.16
2/22/2016	315,602	315,602	29.90		0.15
All Other (1)	3,156	3,156
	2,635,593	2,635,593

(1)Options in the “All Other” category had exercise prices ranging from $27.49 to $32.72. The weighted average exercise price for options outstanding and exercisable in that category was $29.20 for both, while the remaining weighted average contractual term was 0.4 years for both.

Schedule of Nonvested Share Activity

The following table summarizes the activity related to performance share units during 2025:

	Units	Weighted Average Grant Date Fair Value
Unvested at January 1	1,079,495	$	11.51
Units granted	1,011,913	9.30
Units vested	(532,991)	10.93
Units forfeited	(366,646)	10.68
Unvested at December 31	1,191,771	9.64

The following table summarizes the activity related to restricted stock units during 2025:

	Units	Weighted Average Grant Date Fair Value
Unvested at January 1	2,579,631	$	11.96
Units granted	2,284,462	9.64
Units vested	(1,198,894)	10.58
Units forfeited	(582,779)	10.87
Unvested at December 31	3,082,420	10.53
Units vested but not released	1,396,332	9.62
Outstanding at December 31	4,478,752	10.24

Schedule of Stock-based Compensation Expense and Cash Activity

Stock-based compensation expense, cash payments made to settle SARs and cash received from the exercise of stock options follows:

(In millions)	2025		2024		2023
Stock-based compensation expense recognized	$	23	$	23	$	19
Tax benefit	—		(5)		(4)
After-tax stock-based compensation expense	$	23	$	18	$	15
Cash payments to settle SARs	$	—	$	—	$	—
Cash received from stock option exercises	$	1	$	3	$	3